Literature DB >> 7789892

Rising ovarian cancer mortality in the elderly: a manifestation of differential survival.

J E Riggs1.   

Abstract

Ovarian cancer mortality among the elderly in developed countries is increasing. Using published United States mortality data, annual age-specific ovarian cancer mortality rates from 1951 to 1989 were determined for the over-60 age groups and compared to corresponding annual age group population sizes. Rising ovarian cancer mortality rates among the elderly in the United States from 1951 to 1989 were increasingly dependent, with increasing age, upon increasing age group population size. These findings suggest that differential survival, and its effect upon the surviving gene pool in an aging population, may account for some of the observed increase in ovarian cancer mortality rates among recent successive elderly cohorts.

Entities:  

Mesh:

Year:  1995        PMID: 7789892     DOI: 10.1006/gyno.1995.1184

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients.

Authors:  Brent S Pedersen; Panagiotis A Konstantinopoulos; Monique A Spillman; Subhajyoti De
Journal:  Genes Chromosomes Cancer       Date:  2013-05-28       Impact factor: 5.006

2.  Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.

Authors:  Matthew S Block; Bridget Charbonneau; Robert A Vierkant; Zachary Fogarty; William R Bamlet; Paul D P Pharoah; Mary Anne Rossing; Daniel Cramer; Celeste Leigh Pearce; Joellen Schildkraut; Usha Menon; Susanne K Kjaer; Douglas A Levine; Jacek Gronwald; Hoda Anton Culver; Alice S Whittemore; Beth Y Karlan; Diether Lambrechts; Nicolas Wentzensen; Jolanta Kupryjanczyk; Jenny Chang-Claude; Elisa V Bandera; Estrid Hogdall; Florian Heitz; Stanley B Kaye; Peter A Fasching; Ian Campbell; Marc T Goodman; Tanja Pejovic; Yukie T Bean; Laura E Hays; Galina Lurie; Diana Eccles; Alexander Hein; Matthias W Beckmann; Arif B Ekici; James Paul; Robert Brown; James M Flanagan; Philipp Harter; Andreas du Bois; Ira Schwaab; Claus K Hogdall; Lene Lundvall; Sara H Olson; Irene Orlow; Lisa E Paddock; Anja Rudolph; Ursula Eilber; Agnieszka Dansonka-Mieszkowska; Iwona K Rzepecka; Izabela Ziolkowska-Seta; Louise A Brinton; Hannah Yang; Montserrat Garcia-Closas; Evelyn Despierre; Sandrina Lambrechts; Ignace Vergote; Christine S Walsh; Jenny Lester; Weiva Sieh; Valerie McGuire; Joseph H Rothstein; Argyrios Ziogas; Jan Lubiński; Cezary Cybulski; Janusz Menkiszak; Allan Jensen; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Andrew Berchuck; Anna H Wu; Malcolm C Pike; David Van Den Berg; Kathryn L Terry; Allison F Vitonis; Starr M Ramirez; David N Rider; Keith L Knutson; Thomas A Sellers; Catherine M Phelan; Jennifer A Doherty; Sharon E Johnatty; Anna deFazio; Honglin Song; Jonathan Tyrer; Kimberly R Kalli; Brooke L Fridley; Julie M Cunningham; Ellen L Goode
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-16       Impact factor: 4.254

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.